Seroflo Ciphaler 500 mcg

$45.00$117.00

Pack Size Price Price/unit Quantity Add To Cart
1 Multihaler $45.00 $45.00 / Piece
2 Multihaler $84.00 $42.00 / Piece
3 Multihaler $117.00 $39.00 / Piece

Category : INHALER & RESPULES

Seroflo Ciphaler 500 mcg is a medication used in the treatment of Asthma and Chronic Obstructive Pulmonary Disease (COPD).

Quantity Value

1 Multihaler, 2 Multihaler, 3 Multihaler

Active Ingredient (Generic Name):Salmeterol + Fluticasone Propionate
Manufacturer:Cipla Ltd
Packaging:60.0 MDI in 1 box
Strength:500 mcg
Delivery Time:6 To 15 days
SKU:Seroflo Ciphaler 500 mcg

Seroflo Ciphaler 500 mcg is a combination inhaler containing 500 mcg of fluticasone propionate and 50 mcg of salmeterol. Manufactured by Cipla, it is used to manage chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD).

How It Works

  • Fluticasone Propionate: A corticosteroid that reduces inflammation in the airways, helping to prevent asthma attacks and manage COPD symptoms.
  • Salmeterol: A long-acting beta₂-agonist that relaxes the muscles around the airways, making breathing easier.

Together, these medications help to control symptoms and reduce the frequency of flare-ups in asthma and COPD patients.

Indications

  • Asthma: For adults and adolescents aged 12 years and older, one inhalation of 50 mcg salmeterol and 500 mcg fluticasone propionate twice daily.
  • COPD: For patients with significant symptoms despite regular bronchodilator therapy, one inhalation twice daily.

Important Usage Information

  • Not for Acute Attacks: Seroflo Ciphaler is not intended for immediate relief of acute asthma or COPD attacks.
  • Regular Use: It should be used regularly as prescribed, even if you feel well, to maintain control over your symptoms.
  • Proper Technique: Ensure correct inhalation technique to maximize the medication’s effectiveness.

Common Side Effects

  • Upper respiratory tract infections
  • Headache
  • Throat irritation
  • Hoarseness or voice changes
  • Dizziness, nausea, or vomiting

Precautions

  • Oral Hygiene: To prevent oral thrush, rinse your mouth with water and spit it out after each use.
  • Heart Conditions: Consult your doctor if you have a history of heart disease, as salmeterol may increase heart rate.
  • Pregnancy and Breastfeeding: Use only if prescribed by your healthcare provider after assessing the benefits and risks.

Storage Instructions

  • Temperature: Store at room temperature, away from direct sunlight and heat.
  • Safety: Keep out of reach of children.

1. What is Seroflo Ciphaler 500 mcg used for?
Seroflo Ciphaler 500 mcg is used to manage chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It helps control symptoms and prevent flare-ups.

2. How does Seroflo Ciphaler work?
It combines two active ingredients:

  • Fluticasone propionate, a corticosteroid that reduces airway inflammation.
  • Salmeterol, a long-acting bronchodilator that relaxes the muscles in the airways for easier breathing.

Together, they help keep your airways open and reduce symptoms like wheezing and shortness of breath.

3. How should I use Seroflo Ciphaler?

  • Inhalation: One puff (50 mcg of salmeterol and 500 mcg of fluticasone) twice daily or as prescribed by your doctor.
  • Not for immediate relief: Seroflo should not be used for acute asthma attacks or sudden breathing problems.

4. Can Seroflo Ciphaler be used for acute asthma attacks?
No, Seroflo Ciphaler is not for immediate relief of asthma or COPD attacks. You should use a fast-acting bronchodilator (like salbutamol) for quick relief during an attack.

5. What are the common side effects of Seroflo Ciphaler?

  • Sore throat
  • Hoarseness
  • Headache
  • Throat irritation
  • Upper respiratory infections

These side effects are usually mild and go away over time.

Additional information

Quantity Value

1 Multihaler, 2 Multihaler, 3 Multihaler

Reviews

There are no reviews yet.

Be the first to review “Seroflo Ciphaler 500 mcg”

Your email address will not be published. Required fields are marked *